| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $624.6M | +10.4% |
| Cost of Revenue | $322.0M | +4.1% |
| Gross Profit | $302.7M | +18.1% |
| R&D Expense | $137.3M | +5.6% |
| SG&A Expense | $110.2M | +22.2% |
| Operating Income | -$86.1M | +17.9% |
| Pre-tax Income | -$61.8M | +41.7% |
| Income Tax | $3.6M | +22.5% |
| Net Income | -$65.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $229.7M | +15.1% |
| Short-term Investments | $94.4M | -59.6% |
| Accounts Receivable | $42.9M | -8.2% |
| Current Assets | $428.0M | -19.4% |
| Total Assets | $1.20B | -11.0% |
| Current Liabilities | $191.6M | -0.2% |
| Total Liabilities | $752.9M | -19.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $70.3M | +92.3% |
| Capital Expenditures | $5.7M | -49.1% |
| Investing Cash Flow | $113.3M | +168.4% |
| Financing Cash Flow | -$152.0M | -2684.4% |
| Free Cash Flow | $64.6M | +154.3% |
| +40.0% |
| EPS (Basic) | -$1.12 | +41.1% |
| EPS (Diluted) | -$1.12 | +41.1% |
| Stockholders' Equity |
| $448.5M |
| +7.0% |